Electrophysiology of the myoclonus in dementia with Lewy bodies
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Dementia with Lewy bodies (DLB) is the second leading cause of neurodegenerative dementia. Besides dementia, prominent symptoms and signs include parkinsonism, hallucinations, fluctuating mental status, and orthostatic hypotension. Myoclonus has been estimated to occur in 15% of DLB cases. The source of the myoclonus, its electrophysiologic characteristics, and mechanism are unknown. To define the source and properties of the myoclonus in DLB, we examined seven subjects with DLB who had myoclonus, both clinically and electrophysiologically, and compared these characteristics with those of myoclonus in PD.
Methods.
The seven subjects were diagnosed with DLB using consensus criteria and according to Diagnostic and Statistical Manual of Mental Disorders, 4th ed. criteria for dementia that included dementia before parkinsonism, parkinsonism, and hallucinations.1 We performed a neurologic examination, Folstein Mini-Mental State Examination (MMSE), Unified Parkinson’s Disease Rating Scale (UPDRS) motor exam, and Hoehn & Yahr staging. The Unified Myoclonus Rating Scale (UMRS) was used to assess arm/wrist myoclonus amplitude. Electrophysiologic tests were performed as previously published.2 Briefly, each subject had EEG/electromyogram (EMG) polygraphy, back-averaging of myoclonus EMG discharges off-line, median nerve somatosensory evoked potentials (SEPs) …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Dementia with Lewy bodiesBasis of cingulate island signJonathan Graff-Radford, Melissa E. Murray, Val J. Lowe et al.Neurology, July 23, 2014 -
Views & Reviews
DLB and PDD boundary issuesDiagnosis, treatment, molecular pathology, and biomarkersC. F. Lippa, J. E. Duda, M. Grossman et al.Neurology, March 12, 2007 -
Articles
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodiesT.J. Ferman, B.F. Boeve, G.E. Smith et al.Neurology, August 17, 2011 -
Articles
Validity of clinical criteria for the diagnosis of dementia with Lewy bodiesJ. Verghese, H.A. Crystal, D.W. Dickson et al.Neurology, December 01, 1999